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Abstract
Background: Microdeletions at 17q11.2 often encompass NF1 gene, is the cause for NF1 microdeletion syndrome.
Microdeletion at 17q11.2 without the involvement of NF1 gene is rarely reported.
Case presentation: Here we reported a patient carrying a novel de novo deletion at 17q11.2 adjacent to NF1
gene, who presented with developmental delay, short stature, postnatal microcephaly, underweight and
dysmorphic features including flat facial profile, dolicocephaly, hypertelorism, short philtrum, flat nasal bridge
and posteriorly rotated and low set ears. Chromosomal microarray analysis revealed a 1.69 Mb de novo deletion
at 17q11.2 adjacent to NF1 gene, which involves 43 RefSeq genes. We compared this with four overlapping
deletions at this interval.
Conclusions: A rare de novo microdeletion at 17q11.2 not involving NF1 gene is associated with developmental delay
and dysmorphic features. Seven genes, TAOK1, PHF12, NUFIP2, SLC26A4, SEZ6, GIT1 and TRAF4 are possible candidates for
the clinical features of our patient. The delineation of this rare deletion and description of associated clinical
phenotypes will help to understand the genotype-phenotype correlation of genomic imbalances at this locus.
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Background
Chromosomal microarray analysis (CMA) has been
extensively used to investigate submicroscopic copy
number variants (CNVs) that were not detectable by
karyotyping [1]. It has been applied to examining
patients with developmental delay/intellectual disabil-
ity, autism spectrum disorders, and multiple congenital
anomalies [2, 3].
Microdeletions at 17q11.2 region often involve a het-
erozygous 1.5 Mb deletion including NF1 gene, known
as NF1 microdeletion syndrome, which is responsible
for 5–20 % of all patients with neurofibromatosis type
1 (NF1) [4]. The deletion was mediated by non-allelic
homologous recombination between the NF1 repetitive
sequence (REP) [5]. Patients with the typical 1.5 Mb
deletion are also known to have more severe phenotype
than NF1 patients caused by point mutations, which
mean that more than one gene in the 17q11.2 region
may be involved with clinical phenotypes [6]. Microde-
letion at 17q11.2 without the involvement of NF1 gene
has not been reported. Here, we described a novel
microdeletion at 17q11.2 adjacent to NF1 gene in a pa-
tient with developmental delay and dysmorphic facial
features.
Case presentation
The patient was born to a healthy unrelated 25-year-old
mother and a 27-year-old father without family history
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of multiple congenital anomalies, intellectual disability,
recurrent pregnancy loss, or infertility. The girl was born
by natural delivery at 37 weeks of gestation. Her birth
weight was 2.520 kg (approximately, -2SD), length 48 cm
(approximately, -1SD), and head circumference 33.5 cm
(approximately, -1SD). At birth, her metabolic and neo-
natal hearing screening were all normal.
Her develop milestones were delayed. Head holding
was acquired at 6 months of age, she started to sit up at
10 months and walked with support at 21 months. At
age of 21 months, her weight was 7.6 kg (approximately,
-3SD), her height was 76 cm (approximately, -2SD), and
her head circumference was 43.2 cm (approximately,
-3SD). She presented with mild dysmorphic features in-
cluding flat facial profile, dolicocephaly, hypertelorism,
short philtrum, flat nasal bridge and posteriorly rotated
and low set ears. She also had a short fifth finger on
both hand (Fig. 1). Developmental Screening Test
(DST) showed that the DQ and MI scores was 58 and
55, respectively.
Methods and results
DNA samples were extracted from peripheral blood of
the trios using Lab-Aid DNA kit (Zeesan Biotech Co,
Ltd, China), DNA concentration was determined with
NanoDrop ND-2000 spectrophotometer and soft-ware
(NanoDrop Technologies, Berlin, Germany). Genomic
wide single nucleotide polymorphism (SNP) array ana-
lysis was performed using the Illumina infinium-
cytosnp-850 k, which includes over 850 k SNPs in the
human genome. Hybridization and array scanning were
performed according to the manufacturer’s instruction.
Data were analyzed with Illumina Genome Studio and
KaryoStudio software. CNVs identified in the samples
were visualized by using the UCSC Genome Browser
website (http://genome.ucsc.edu) and compared to the
Database of Genomic Variants (http://projects.tcag.ca/
variation) to exclude CNVs considered as benign vari-
ants. The Decipher database and CNV Morbidity Map
of Developmental Delay were consulted as resources to
aid genotype-phenotype correlation.
Fig. 1 Clinical features of the patients. Note the facial profile, dolicocephaly and low-set posteriorly rotated ear (a); hypertelorism, low nasal bridge
and short philtrum (b); short fifth fingers (c and d)
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A deletion of 1,697,561 bp on chromosome 17 (Fig. 2a)
was detected (chr17:27,064,286-28,761,847) (hg19). This
position correspond to cytogenetic bands 17q11.2. The
chromosomal constitution of the patient was reported as
following: arr17q11.2(27064286-28761847) × 1. The par-
ents did not carry the 1.69 Mb copy number variant
(CNV), indicating a de novo origin of the rearrangement.
The deletion involves 43 genes.
Discussion
Here we presented a 17q11.2 de novo deletion character-
ized by SNP array in a patient with developmental delay
and mild dysmorphic features. This is a novel deletion,
relative large in size and not listed among the reported
CNVs in phenotypically normal individuals in the Data-
base of Genomic Variants, therefore, it is considered as a
likely pathogenic CNV.
We searched literature and databases for overlap-
ping deletions at this interval without the involvement
of NF1 gene. There are only four deletion cases cur-
rently reported within this interval, all are much
smaller in size (Fig. 2b). One (nsv1062993) is reported
in the morbidity map of developmental delay, and the
other three (#250045, #287702, #1973) are reported in
the Decipher database. The case #250045, presented
with microcephaly and seizures, carrying a de novo de-
letion of 38 kb (chr17:27771342-27809321) involving
part of TAOK1 gene. The case with 72 kb deletion
(chr17:27730573-27802767) from the morbidity map
of developmental delay (nsv1062993) also intercept
with TAOK1 gene but the inheritance status and de-
tailed clinical phenotypes are not known, except the
patient is presumed to have developmental delay. The
deletion nsv1062993 completely overlaps the CNV of
#250045, and the two partial overlap TAOK1 gene, we
assume that TAOK1 gene plays an important role in the
phenotype of patient. The patient #287702 carried a de
novo deletion of 17q11.2 (chr17:27837697-28120076) and
a maternally inherited duplication of 15q13.3, and showed
dysphasia, poor motor coordination and specific learning
disability. The patient #1973 carried a deletion of 173 kb
(chr17:28496019-28669139) in size, involving genes
including SLC6A4, BLMH and part of NSRP1. He
showed depression, intellectual disability and psychosis.
Fig. 2 SNP array profile showing a deletion on 17q11.2 (a), and schematic representation of 27 Mbp to 31Mbp in 17q11.2 region (b). Blue bars
represent genes discussed in this paper. Also shown, the extent of the deletions (in red) observed in reported cases are compared with the
presented case
Xie et al. Molecular Cytogenetics  (2016) 9:41 Page 3 of 5
The breakpoints of this four cases are different, how-
ever, their phenotype have some common ground,
mainly defined on the basis of the central nervous
system.
There are a total of 43 RefSeq genes involved in the
deletion in our patient. Seven genes (FAM222B, BLMH,
PHF12, CRYBA1, NUFIP2, TAOK1 and SLC6A4) were
predicted to have a haploinsufficiency score less than 10,
suggestive of possible clinical consequences with one
copy deletion. Little clue is available about the potential
relationship of FAM222B and BLMH with neurodeve-
lopment. PHF12 is a type of PHD (plant homeodomain)
finger protein, acts as a transcriptional repressor. Several
proteins with PHD finger are known to epigenetically
regulate gene expression and loss of function mutations
are associated with intellectual disability phenotypes in
human [7, 8]. CRYBA1 is one of the β-crystallins families,
encoding both the beta-A3- and beta-A1-crystallins. Dif-
ferent beta-crystallin proteins can interact with each other
and other lens proteins, which play a key role in maintain-
ing the transparency of the lens. The mutations of
CRYBA1 may be destroy the structure and function of
crystallins leading to abnormalities in the development
and maturation of the retinal vasculature, and have been
identified to be causative for congenital cataracts [9, 10].
Up to now, the patient did not present typical phenotype
of congenital cataracts, it may be associated with the
phenotypic heterogeneity of congenital cataracts.
NUFIP2 (nuclear fragile X mental retardation protein
interacting protein 2) gene encodes an 82-kD protein
(called 82-FIP), distributed in various regions of the
brain. It was demonstrated that NUFIP2 interacts with
FMRP, whose absence causes the fragile-X syndrome
[11]. 82-FIP might have a role in the development of the
nervous system and in cognitive function. The deregula-
tion of NUFIP2 was reported to be associated with men-
tal retardation or cognitive impairment [12].
The gene of TAOK1 has the lowest predicted haploin-
sufficiency score. It encodes hTAOK1, which is a mem-
ber of the Ste20 group of kinases with the kinase
domain located at the N-terminus. hTAOK1 was ini-
tially cloned from human fetal brain [13], and highly
expressed in human brain, as shown by Northern ana-
lysis (http://www.kazusa.or.jp/huge/gfpage/KIAA1361/).
TAOK1 may play a role in the developing human brain
by inducing neuronal apoptosis and regulating micro-
tubule dynamics and checkpoint signaling [14, 15]. Of
significance, the case nsv1062993 and #250045 both
partially overlapped TAOK1 gene, presenting develop-
mental delay and microcephaly, respectively. Accord-
ingly, we hypothesize that TAOK1 might be involved in
the developmental delay and microcephaly in our
patient. In addition, a closely related family member
TAOK2 is regarded as a autism spectrum disorder
susceptibility gene, are shown to regulated basal den-
drite development in cortical neurons [16].
The solute carrier family 6 (serotonin neurotransmit-
ter transporter) member 4 gene (SLC6A4) encodes an
integral membrane protein that transports the neuro-
transmitter serotonin from synaptic spaces into pre-
synaptic neurons. Therefore, SLC6A4 gene may play a
role in terminating the synaptic actions of serotonin
and recycles it into the neurotransmitter pool [17]. Al-
lelic heterogeneity at this gene have been implicated in
speech delay, atypical autism, anxiety and obsessive
compulsive disorder [18].
In addition, several other genes are known to be func-
tionally important for the development and function of
the central nervous system.
SEZ6 (seizure related 6 homolog (mouse)) specific ex-
presses in the brain, especially in the developing fore-
brain [19]. SEZ6 may have the function on cell adhesion
or recognition and protein-protein interaction [20]. The
mutations of SEZ6 were associated with febrile seizures
and epilepsy [21].
GIT1 (G protein-coupled receptor kinase interacting
ArfGAP 1) is a multifunctional signaling adaptor pro-
tein. GIT1 interacts with various proteins and forms
signaling complex to modulate the development of den-
dritic spines and neuronal synapses [22]. Git1–/– mice
and dGitex21C Drosophila mutant were studied and
displayed a microcephaly-like brain size reduction de-
creased neuronal cell body size, and behavioral deficits
such as impaired motor coordination and learning [23].
TRAF4 gene encodes a member of the TNF receptor
associated factor (TRAF) family. TRAF proteins are as-
sociated with, and mediate signal transduction from
members of the TNF receptor superfamily. TRAF4 pro-
tein has been shown to interact with neurotrophin
receptor, p75 (NTR/NTSR1), and negatively regulate
NTR induced cell death and NF-kappa B activation [24].
TRAF4-deficient mice exhibited a high incidence of
spina bifida, a defect likened to neural tube defects
(NTDs), which revealed that TRAF4 participates in neu-
rulation in vivo [25].
Thus, multiple genes at this interval are likely contrib-
uting to the clinical presentations of our patient. Further
study is warranted to understand the underlying patho-
logical mechanism.
Conclusions
We described a patient with developmental delay, short
stature, postnatal microcephaly, underweight and dys-
morphic features. A novel deletion adjacent to the NF1
locus was detected. Several genes are functionally im-
portant for neurodevelopment and candidate for this
novel microdeletion disorder. Additional overlapping
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cases will help to better understand the clinical presenta-
tion of this disorder and critical genes involved.
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